Internal Medicine, Hematology & Oncology · American Fork, UT
NPI
1891106936
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1152 E 200 N
American Fork, UT, 84003
Phone (801) 772-0698
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
91,132 services
Medicare patients, 2024
284
Average age 75
Drug cost, 2024
$3.8M
1,443 prescriptions
Company payments, 2025
$3,762
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicholas Thomson was code J0897 (injection, denosumab, 1 mg), 9,060 times for 43 patients. In total Nicholas Thomson billed 91,132 services in 137 codes, and Medicare paid $2.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 9,060 | 43 | $20.48 | $186K |
| 85025 Blood Count | Office | 471 | 122 | $7.61 | $3,584 |
| 80053 Clinical Chemistry | Office | 321 | 96 | $10.35 | $3,322 |
| 36415 Venipuncture Blood Collection | Office | 316 | 116 | $8.65 | $2,733 |
| 99214 Office E&M - Established | Office | 225 | 112 | $85.92 | $19K |
| 96372 Injection Administration | Office | 196 | 66 | $10.02 | $1,964 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 178 | 94 | $12.08 | $2,151 |
| 96413 Chemotherapy Administration | Office | 156 | 35 | $86.07 | $13K |
| 99215 Office E&M - Established | Office | 151 | 61 | $130.13 | $20K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 139 | 25 | $4.50 | $626 |
| 96365 Intravenous Infusion, Hydration | Office | 125 | 48 | $42.57 | $5,322 |
| 96401 Chemotherapy Administration | Office | 123 | 12 | $49.74 | $6,118 |
| 96367 Intravenous Infusion, Hydration | Office | 88 | 18 | $20.48 | $1,802 |
| 82378 Clinical Chemistry | Office | 55 | 19 | $18.58 | $1,022 |
| 96415 Chemotherapy Administration | Office | 46 | 12 | $16.90 | $777 |
By year: 2022 $1.5M for 89,769 services; 2023 $1.8M for 95,911 services; 2024 $2.0M for 91,132 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 471 | 122 | $7.61 | $3,584 |
| 80053 Clinical Chemistry | 321 | 96 | $10.35 | $3,322 |
| 36415 Venipuncture Blood Collection | 316 | 116 | $8.65 | $2,733 |
| 82378 Clinical Chemistry | 55 | 19 | $18.58 | $1,022 |
| 82728 Clinical Chemistry | 32 | 17 | $13.36 | $428 |
| 83615 Clinical Chemistry | 25 | 13 | $5.92 | $148 |
| 82232 Clinical Chemistry | 25 | 11 | $15.86 | $397 |
| 83540 Clinical Chemistry | 21 | 15 | $6.34 | $133 |
| 83550 Clinical Chemistry | 21 | 15 | $8.57 | $180 |
Medicare prescription drug claims, 2024
In 2024, the drug Nicholas Thomson prescribed most often to Medicare patients was Anastrozole, with 98 prescriptions and refills. In total Nicholas Thomson wrote 1,443 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 98 | 296 | 31 | $2,603 |
| Letrozole Generic | 71 | 125 | 19 | $1,248 |
| Tamoxifen Citrate Generic | 62 | 126 | 14 | $1,184 |
| Acyclovir Generic | 52 | 59 | Under 11 | $619 |
| Eliquis Apixaban | 48 | 75 | 14 | $42K |
| Levothyroxine Sodium Generic | 48 | 62 | 11 | $207 |
| Verzenio Abemaciclib | 44 | 44 | Under 11 | $683K |
| Revlimid Lenalidomide | 40 | 40 | Under 11 | $682K |
| Brukinsa Zanubrutinib | 39 | 40 | Under 11 | $464K |
| Dexamethasone Generic | 38 | 44 | Under 11 | $586 |
| Hydroxyurea Generic | 31 | 53 | Under 11 | $657 |
| Gabapentin Generic | 31 | 31 | Under 11 | $571 |
| Tamsulosin Hcl Generic | 30 | 45 | Under 11 | $319 |
| Ondansetron Hcl Generic | 29 | 31 | Under 11 | $525 |
| Ondansetron Odt Ondansetron | 28 | 28 | 24 | $1,110 |
Brand drugs: 346 claims; generic drugs: 1,097 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicholas Thomson $3,762 ($3,762 in general payments such as food, travel and fees) from 37 companies. The largest payer was Novartis Pharmaceuticals Corporation with $751.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 20 | $751 |
| Pfizer Inc. PFE | 19 | $295 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $259 |
| Merck Sharp & Dohme LLC MRK | 11 | $231 |
| Incyte Corporation INCY | 9 | $221 |
| Astellas Pharma US Inc 4503.T | 7 | $168 |
| Daiichi Sankyo Inc. 4568.T | 11 | $163 |
| Array Biopharma Inc PFE | 8 | $118 |
| EMD Serono, Inc. MRK.DE | 4 | $116 |
| Eisai Inc. 4523.T | 6 | $116 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.